Hepatocellular carcinoma and hepatitis virus

Area of Science:

• Hepatology and viral oncology.

Background:

• Hepatocellular carcinoma (HCC) frequently harbors integrated hepatitis B virus (HBV) DNA, implying a direct role in oncogenesis.
• Deregulation of cell cycle genes and altered transcriptome profiles are common in HCC patients.
• The HBV-encoded HBx protein is implicated in multistep carcinogenesis by affecting apoptosis, DNA repair, and gene transcription.

Purpose of the Study:

• To explore the oncogenic mechanisms of HBV in hepatocellular carcinoma.
• To understand the role of HBV DNA integration and HBx protein in hepatocyte transformation.
• To investigate the impact of HBV replication on HCC patient survival.

Main Methods:

• Analysis of integrated HBV DNA in HCC tissues.
• Examination of cellular gene expression and protein function related to cell cycle and apoptosis.
• Assessment of mutagenic species and DNA damage in hepatocytes.

Main Results:

• Integrated HBV DNA suggests direct interaction with transformation-associated genes in HCC.
• HBx protein modulates key cellular processes including apoptosis and DNA repair.
• Hepatocyte transformation can be influenced by HBV DNA integration, reactive oxygen species, and mutations.
• HBV replication within HCC impacts patient survival.

Conclusions:

• HBV plays a direct and indirect role in the development of hepatocellular carcinoma.
• Targeting HBV infection is crucial for reducing the global burden of HCC.
• Understanding HBV's oncogenic pathways is vital for developing effective therapies.